Surface Oncology (SURF) Competitor Comparison
We are evaluating the key criteria listed to compare Surface Oncology (SURF) against its competitors in the Biotechnology industry.
Market Capitalization
287 / 368Gross Profits
185 / 278Total Revenue
287 / 300EBITDA
188 / 337Free Cashflow
163 / 352Quick Ratio
135 / 357Earnings per Share
191 / 359Dividend yield
0 / 6Total Cash
215 / 358Performance 3 years
260 / 368Performance 5 years
279 / 368Performance 10 years
263 / 368Linearity 3 years
152 / 368Linearity 5 years
249 / 368Linearity 10 years
219 / 368Total Rank
269 / 368Dividend Rank
278 / 368Valuation Rank
40 / 368Piotroski Rank
121 / 368Muliplier Rank
53 / 368Piotroski Rank - SURF ranking 121 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.